Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating the efficacy and safety of AK111 in active ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• AK111

Snippet

Sponsor: Akeso | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED